624 related articles for article (PubMed ID: 10832104)
1. Graves' ophthalmopathy: eye muscle involvement in patients with diplopia.
Nagy EV; Toth J; Kaldi I; Damjanovich J; Mezosi E; Lenkey A; Toth L; Szabo J; Karanyi Z; Leovey A
Eur J Endocrinol; 2000 Jun; 142(6):591-7. PubMed ID: 10832104
[TBL] [Abstract][Full Text] [Related]
2. Clinical challenge: An orbital Hickam's dictum.
Wilson ME; Thornton S; Murchison AP; Bilyk JR
Surv Ophthalmol; 2016; 61(6):799-805. PubMed ID: 26994869
[TBL] [Abstract][Full Text] [Related]
3. [MR relaxation time measurements with and without selective fat suppression (SPIR) in endocrine orbitopathy].
Pauleit D; Schüller H; Textor J; Leutner C; Keller E; Sommer T; Träber F; Block W; Boldt I; Schild H
Rofo; 1997 Dec; 167(6):557-64. PubMed ID: 9465949
[TBL] [Abstract][Full Text] [Related]
4. The usefulness of quantitative orbital magnetic resonance imaging in Graves' ophthalmopathy.
Prummel MF; Gerding MN; Zonneveld FW; Wiersinga WM
Clin Endocrinol (Oxf); 2001 Feb; 54(2):205-9. PubMed ID: 11207635
[TBL] [Abstract][Full Text] [Related]
5. MR T2 relaxation time for the assessment of retrobulbar inflammation in Graves' ophthalmopathy.
Utech CI; Khatibnia U; Winter PF; Wulle KG
Thyroid; 1995 Jun; 5(3):185-93. PubMed ID: 7580266
[TBL] [Abstract][Full Text] [Related]
6. Three dimensional orbital magnetic resonance T2-mapping in the evaluation of patients with Graves' ophthalmopathy.
Hou K; Ai T; Hu WK; Luo B; Wu YP; Liu R
J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):938-942. PubMed ID: 29270757
[TBL] [Abstract][Full Text] [Related]
7. Pure eye muscle involvement in endocrine orbitopathy.
Gerlach M; Ferbert A
Eur Neurol; 2008; 60(2):67-72. PubMed ID: 18480610
[TBL] [Abstract][Full Text] [Related]
8. Age-related difference in extraocular muscles and its relation to clinical manifestations in an ethnically homogenous group of patients with Graves' orbitopathy.
Su Y; Liu X; Fang S; Huang Y; Li Y; Zhong S; Wang Y; Zhang S; Zhou H; Sun J; Fan X
Graefes Arch Clin Exp Ophthalmol; 2022 Feb; 260(2):583-589. PubMed ID: 34477926
[TBL] [Abstract][Full Text] [Related]
9. Correlation of orbital muscle changes evaluated by magnetic resonance imaging and thyroid-stimulating antibody in patients with Graves' ophthalmopathy.
Nishikawa M; Yoshimura M; Toyoda N; Masaki H; Yonemoto T; Gondou A; Kato T; Kurokawa H; Furumura T; Inada M
Acta Endocrinol (Copenh); 1993 Sep; 129(3):213-9. PubMed ID: 8105634
[TBL] [Abstract][Full Text] [Related]
10. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound measurement of the horizontal external eye muscles in patients with thyroid disease. Is orbital involvement associated with thyroid autoantibodies?
Zimmermann-Belsing T; Feldt-Rasmussen U; Fledelius H
Eur J Ophthalmol; 2002; 12(5):351-8. PubMed ID: 12474915
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging in diagnosis and follow-up of minimal thyroid ophthalmopathy.
Matsuo H; Motomura M; Takeo G; Yoshimura T; Tsujihata M; Nagataki S
Jpn J Med; 1991; 30(3):229-32. PubMed ID: 1920963
[TBL] [Abstract][Full Text] [Related]
13. Rectus extraocular muscle paths and decompression surgery for Graves orbitopathy: mechanism of motility disturbances.
Abràmoff MD; Kalmann R; de Graaf ME; Stilma JS; Mourits MP
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):300-7. PubMed ID: 11818370
[TBL] [Abstract][Full Text] [Related]
14. Volume changes in intra- and extraorbital compartments in patients with Graves' ophthalmopathy: effect of smoking.
Szucs-Farkas Z; Toth J; Kollar J; Galuska L; Burman KD; Boda J; Leovey A; Varga J; Ujhelyi B; Szabo J; Berta A; Nagy EV
Thyroid; 2005 Feb; 15(2):146-51. PubMed ID: 15753674
[TBL] [Abstract][Full Text] [Related]
15. A quantitative analysis of orbital soft tissue in Graves' disease based on B-mode ultrasonography.
Yamamoto K; Itoh K; Yoshida S; Saito K; Sakamoto Y; Matsuda A; Saito T; Kuzuya T
Endocrinol Jpn; 1979 Apr; 26(2):255-61. PubMed ID: 582582
[TBL] [Abstract][Full Text] [Related]
16. Untreated Graves' disease patients without clinical ophthalmopathy demonstrate a high frequency of extraocular muscle (EOM) enlargement by magnetic resonance.
Villadolid MC; Yokoyama N; Izumi M; Nishikawa T; Kimura H; Ashizawa K; Kiriyama T; Uetani M; Nagataki S
J Clin Endocrinol Metab; 1995 Sep; 80(9):2830-3. PubMed ID: 7673432
[TBL] [Abstract][Full Text] [Related]
17. [The course of the disease in endocrine orbitopathy. Magnetic resonance tomographic documentation].
Hosten N; Schörner W; Lietz A; Wenzel KW
Rofo; 1992 Sep; 157(3):210-4. PubMed ID: 1391813
[TBL] [Abstract][Full Text] [Related]
18. Significance of orbital fatty tissue for exophthalmos in thyroid-associated ophthalmopathy.
Nishida Y; Tian S; Isberg B; Hayashi O; Tallstedt L; Lennerstrand G
Graefes Arch Clin Exp Ophthalmol; 2002 Jul; 240(7):515-20. PubMed ID: 12136278
[TBL] [Abstract][Full Text] [Related]
19. Affinity purification of orbital membrane antigens for the study of the pathogenesis of Graves' ophthalmopathy.
Salvi M; Bingoye F; Chung F; Wall JR
J Clin Endocrinol Metab; 1988 May; 66(5):939-45. PubMed ID: 3360902
[TBL] [Abstract][Full Text] [Related]
20. Increased retinal blood flow in patients with Graves' disease: influence of thyroid function and ophthalmopathy.
Kurioka Y; Inaba M; Kawagishi T; Emoto M; Kumeda Y; Inoue Y; Morii H; Nishizawa Y
Eur J Endocrinol; 2001 Feb; 144(2):99-107. PubMed ID: 11182745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
